Peter G. Carroll

---

Education

Western New England College of Law, J.D., cum laude, 1986
Tufts University School of Medicine, Ph.D., Immunology, 1983
Harvard University, School of Extension Studies, B.A., 1983

---

Professional Experience

Partner, Medlen & Carroll, LLP, 1992 – Present
Associate, Limbach, Limbach & Sutton, 1987 – 1992
Senior Scientist, Travenol-Genentech Diagnostics, Inc., 1984 – 1986
Postdoctoral Research Fellow, Eunice Kennedy Shriver Center, Biochemistry Department, 1983 – 1984

---

Concentration

Biotechnology Patent Prosecution and Appeals; Licensing; Litigation; and Expert Witness for Biotechnology Cases

---

Admitted

United States Court of Appeals for the Federal Circuit, 1992
United States Patent and Trademark Office, 1988
State Bar of California, 1987
State Bar of Massachusetts, 1986
State Bar of Ohio, 1996

---

Representative Cases

Hoffmann-LaRoche, Inc. v. Promega Corporation, 33 USPQ2d 1641 (N.D. Cal 1994), 1999 U.S. Dist. LEXIS 19059 (N.D. Cal 1999), 323 F.3d 1354, 66 USPQ2d 1385 (Fed. Cir. 2003), 2003 US. App. LEXIS 14802 (Fed. Cir. 2003)

Roger W. Giese v. Pierce Chemical Company and Vector Laboratories, Inc., 29 F.Supp.2d 33, 49 U.S.P.Q.2d 1998 (D. Mass. 1998); 50 U.S.P.Q.2d 1810 (D.Mass. 1999)

Promega Corporation v. Lifecodes Corporation, American Arbitration Association (1992)

Vacco Industries, Inc. v. van den Berg, 5 Cal. App. 4th 34, 6 Cal. Rptr. 2d 602 (2d Dist. 1992)

---

Representative Publications

“Murine Monoclonal Anti-DNA Antibodies Bind to Endogenous Bacteria,” J. Immunol., 135:1086 (1985)

“Immune Properties of Human Teratocarcinoma Cells: Human Teratocarcinoma Targets Distinguish Between Natural Killer and Activated Killer Cells,” J. Immunol., 131:1997 (1983)